{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Crimean\u2013Congo haemorrhagic fever", "epitope-based vaccine", "epitopes prediction", "immunoinformatics", "multi-epitope vaccine", "vaccine design"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36679906", "DateRevised": {"Year": "2023", "Month": "11", "Day": "06"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "27"}], "Language": ["eng"], "ELocationID": ["61", "10.3390/vaccines11010061"], "Journal": {"ISSN": "2076-393X", "JournalIssue": {"Volume": "11", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Dec", "Day": "27"}}, "Title": "Vaccines", "ISOAbbreviation": "Vaccines (Basel)"}, "ArticleTitle": "An Immunoinformatics Approach to Design a Potent Multi-Epitope Vaccine against Asia-1 Genotype of Crimean-Congo Haemorrhagic Fever Virus Using the Structural Glycoproteins as a Target.", "Abstract": {"AbstractText": ["Crimean-Congo haemorrhagic fever (CCHF), caused by Crimean-Congo haemorrhagic fever virus (CCHFV), is a disease of worldwide importance (endemic yet not limited to Asia, Middle East, and Africa) and has triggered several outbreaks amounting to a case fatality rate of 10-40% as per the World Health Organization. Genetic diversity and phylogenetic data revealed that the Asia-1 genotype of CCHFV remained dominant in Pakistan, where 688 confirmed cases were reported between the 2012-2022 period. Currently, no approved vaccine is available to tackle the viral infection. Epitope-based vaccine design has gained significant attention in recent years due to its safety, timeliness, and cost efficiency compared to conventional vaccines. In the present study, we employed a robust immunoinformatics-based approach targeting the structural glycoproteins G1 and G2 of CCHFV (Asia-1 genotype) to design a multi-epitope vaccine construct. Five B-cells and six cytotoxic T-lymphocytes (CTL) epitopes were mapped and finalized from G1 and G2 and were fused with suitable linkers (EAAAK, GGGS, AAY, and GPGPG), a PADRE sequence (13 aa), and an adjuvant (50S ribosomal protein L7/L12) to formulate a chimeric vaccine construct. The selected CTL epitopes showed high affinity and stable binding with the binding groove of common human HLA class I molecules (HLA-A*02:01 and HLA-B*44:02) and mouse major histocompatibility complex class I molecules. The chimeric vaccine was predicted to be an antigenic, non-allergenic, and soluble molecule with a suitable physicochemical profile. Molecular docking and molecular dynamics simulation indicated a stable and energetically favourable interaction between the constructed antigen and Toll-like receptors (TLR2, TLR3, and TLR4). Our results demonstrated that innate, adaptive, and humoral immune responses could be elicited upon administration of such a potent muti-epitope vaccine construct. These results could be helpful for an experimental vaccinologist to develop an effective vaccine against the Asia-1 genotype of CCHFV."]}, "AuthorList": [{"Identifier": ["0000-0003-3162-7650"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre of Excellence in Molecular Biology, University of the Punjab, Lahore 53700, Pakistan."}], "LastName": "Shah", "ForeName": "Syed Zawar", "Initials": "SZ"}, {"Identifier": ["0000-0002-9577-1793"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre of Excellence in Molecular Biology, University of the Punjab, Lahore 53700, Pakistan."}], "LastName": "Jabbar", "ForeName": "Basit", "Initials": "B"}, {"Identifier": ["0000-0001-9120-2414"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON N9B 3P4, Canada."}], "LastName": "Mirza", "ForeName": "Muhammad Usman", "Initials": "MU"}, {"Identifier": ["0000-0001-6115-9689"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Genetic Engineering, Hazara University Mansehra, Mansehra 21120, Pakistan."}, {"Identifier": [], "Affiliation": "Natural and Medical Sciences Research Center, University of Nizwa, Birkat-ul-Mouz 616, Oman."}], "LastName": "Waqas", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": ["0000-0002-6565-6989"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biotechnology and Genetic Engineering, The University of Agriculture, Peshawar 25130, Pakistan."}], "LastName": "Aziz", "ForeName": "Shahkaar", "Initials": "S"}, {"Identifier": ["0000-0001-8526-7799"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural and Medical Sciences Research Center, University of Nizwa, Birkat-ul-Mouz 616, Oman."}], "LastName": "Halim", "ForeName": "Sobia Ahsan", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Genetic Engineering, Hazara University Mansehra, Mansehra 21120, Pakistan."}], "LastName": "Ali", "ForeName": "Amjad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre of Excellence in Molecular Biology, University of the Punjab, Lahore 53700, Pakistan."}], "LastName": "Rafique", "ForeName": "Shazia", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre of Excellence in Molecular Biology, University of the Punjab, Lahore 53700, Pakistan."}], "LastName": "Idrees", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": ["0000-0001-8734-2588"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Substance Abuse and Toxicology Research Center, Jazan University, P.O. Box 114, Jazan 45142, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants and Traditional Medicine Research Institute, National Center for Research, P.O. Box 2404, Khartoum 11111, Sudan."}], "LastName": "Khalid", "ForeName": "Asaad", "Initials": "A"}, {"Identifier": ["0000-0003-4770-9319"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia."}], "LastName": "Abdalla", "ForeName": "Ashraf N", "Initials": "AN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural and Medical Sciences Research Center, University of Nizwa, Birkat-ul-Mouz 616, Oman."}], "LastName": "Khan", "ForeName": "Ajmal", "Initials": "A"}, {"Identifier": ["0000-0002-0815-5942"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural and Medical Sciences Research Center, University of Nizwa, Birkat-ul-Mouz 616, Oman."}], "LastName": "Al-Harrasi", "ForeName": "Ahmed", "Initials": "A"}], "GrantList": [{"GrantID": "22UQU4331128DSR23", "Agency": "Umm al-Qura University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Vaccines (Basel)", "NlmUniqueID": "101629355", "ISSNLinking": "2076-393X"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Al-Abri S.S., Abaidani I.A., Fazlalipour M., Mostafavi E., Leblebicioglu H., Pshenichnaya N., Memish Z.A., Hewson R., Petersen E., Mala P., et al. Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: Issues, challenges, and future directions. Int. J. Infect Dis. 2017;58:82\u201389. doi: 10.1016/j.ijid.2017.02.018.", "ArticleIdList": ["10.1016/j.ijid.2017.02.018", "PMC7110796", "28259724"]}, {"Citation": "Elliott R.M., Pljusnin A. Bunyaviridae: Molecular and Cellular Biology. Caister Acad. Press; Norfolk, UK: 2011."}, {"Citation": "Deyde V.M., Khristova M.L., Rollin P.E., Ksiazek T.G., Nichol S.T. Crimean-Congo hemorrhagic fever virus genomics and global diversity. J. Virol. 2006;80:8834\u20138842. doi: 10.1128/JVI.00752-06.", "ArticleIdList": ["10.1128/JVI.00752-06", "PMC1563879", "16912331"]}, {"Citation": "Sanchez A.J., Vincent M.J., Nichol S.T. Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J. Virol. 2002;76:7263\u20137275. doi: 10.1128/JVI.76.14.7263-7275.2002.", "ArticleIdList": ["10.1128/JVI.76.14.7263-7275.2002", "PMC136317", "12072526"]}, {"Citation": "Haferkamp S., Fernando L., Schwarz T.F., Feldmann H., Flick R. Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins. Virol. J. 2005;2:42. doi: 10.1186/1743-422X-2-42.", "ArticleIdList": ["10.1186/1743-422X-2-42", "PMC1090624", "15850490"]}, {"Citation": "Bertolotti-Ciarlet A., Smith J., Strecker K., Paragas J., Altamura L.A., McFalls J.M., Frias-Staheli N., Garcia-Sastre A., Schmaljohn C.S., Doms R.W. Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins. J. Virol. 2005;79:6152\u20136161. doi: 10.1128/JVI.79.10.6152-6161.2005.", "ArticleIdList": ["10.1128/JVI.79.10.6152-6161.2005", "PMC1091677", "15858000"]}, {"Citation": "Sahin E., Cihan A.\u00c7., Aligholipour T., Foldes K., Engin E.D., \u00d6zkul A. Assessment of the Immunogenicity and Protective Aspects of a DNA Vaccine Targeting Crimean Congo Hemorrhagic Fever Virus Glycoprotein Gc. Duzce Med. J. 2021;23:66\u201375. doi: 10.18678/dtfd.864114.", "ArticleIdList": ["10.18678/dtfd.864114"]}, {"Citation": "Buttigieg K.R., Dowall S.D., Findlay-Wilson S., Miloszewska A., Rayner E., Hewson R., Carroll M.W. A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model. PLoS ONE. 2014;9:e91516. doi: 10.1371/journal.pone.0091516.", "ArticleIdList": ["10.1371/journal.pone.0091516", "PMC3951450", "24621656"]}, {"Citation": "Kortekaas J., Vloet R.P., McAuley A.J., Shen X., Bosch B.J., de Vries L., Moormann R.J., Bente D.A. Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice. Vector Borne Zoonotic Dis. 2015;15:759\u2013764. doi: 10.1089/vbz.2015.1855.", "ArticleIdList": ["10.1089/vbz.2015.1855", "PMC7643766", "26684523"]}, {"Citation": "Chumakov M.P. Studies of virus haemorrhagic fevers. J. Hyg. Epidemiol. Microbiol. Immunol. 1963;7:125\u2013135.", "ArticleIdList": ["14040683"]}, {"Citation": "Erg\u00f6n\u00fcl \u00d6. Crimean-Congo haemorrhagic fever. Lancet Infect. Dis. 2006;6:203\u2013214. doi: 10.1016/S1473-3099(06)70435-2.", "ArticleIdList": ["10.1016/S1473-3099(06)70435-2", "PMC7185836", "16554245"]}, {"Citation": "Hoogstraal H. Review Article 1: The Epidemiology of Tick-Borne Crimean-Congo Hemorrhagic Fever in Asia, Europe, and Africa 2 3. J. Med. Entomol. 1979;15:307\u2013417. doi: 10.1093/jmedent/15.4.307.", "ArticleIdList": ["10.1093/jmedent/15.4.307", "113533"]}, {"Citation": "Maltezou H.C., Papa A. Crimean-Congo hemorrhagic fever: Risk for emergence of new endemic foci in Europe? Travel Med. Infect. Dis. 2010;8:139\u2013143. doi: 10.1016/j.tmaid.2010.04.008.", "ArticleIdList": ["10.1016/j.tmaid.2010.04.008", "20541133"]}, {"Citation": "Oany A.R., Ahmad S.A.I., Hossain M.U., Jyoti T.P. Identification of highly conserved regions in L-segment of Crimean\u2013Congo hemorrhagic fever virus and immunoinformatic prediction about potential novel vaccine. Adv. Appl. Bioinform. Chem. AABC. 2015;8:1. doi: 10.2147/AABC.S75250.", "ArticleIdList": ["10.2147/AABC.S75250", "PMC4293217", "25609983"]}, {"Citation": "Burt F.J., Swanepoel R., Shieh W.J., Smith J.F., Leman P.A., Greer P.W., Coffield L.M., Rollin P.E., Ksiazek T.G., Peters C.J., et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch. Pathol. Lab. Med. 1997;121:839\u2013846.", "ArticleIdList": ["9278612"]}, {"Citation": "Peyrefitte C.N., Perret M., Garcia S., Rodrigues R., Bagnaud A., Lacote S., Crance J.M., Vernet G., Garin D., Bouloy M., et al. Differential activation profiles of Crimean-Congo hemorrhagic fever virus- and Dugbe virus-infected antigen-presenting cells. J. Gen. Virol. 2010;91:189\u2013198. doi: 10.1099/vir.0.015701-0.", "ArticleIdList": ["10.1099/vir.0.015701-0", "19812268"]}, {"Citation": "Connolly-Andersen A.M., Douagi I., Kraus A.A., Mirazimi A. Crimean Congo hemorrhagic fever virus infects human monocyte-derived dendritic cells. Virology. 2009;390:157\u2013162. doi: 10.1016/j.virol.2009.06.010.", "ArticleIdList": ["10.1016/j.virol.2009.06.010", "19570561"]}, {"Citation": "Connolly-Andersen A.M., Moll G., Andersson C., Akerstrom S., Karlberg H., Douagi I., Mirazimi A. Crimean-Congo hemorrhagic fever virus activates endothelial cells. J. Virol. 2011;85:7766\u20137774. doi: 10.1128/JVI.02469-10.", "ArticleIdList": ["10.1128/JVI.02469-10", "PMC3147921", "21632768"]}, {"Citation": "Kraus A.A., Mirazimi A. Molecular biology and pathogenesis of Crimean\u2013Congo hemorrhagic fever virus. Future Virol. 2010;5:469\u2013479. doi: 10.2217/fvl.10.23.", "ArticleIdList": ["10.2217/fvl.10.23"]}, {"Citation": "Duygu F., Kaya T., Baysan P. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: Is ribavirin treatment suitable? Vector-Borne Zoonotic Dis. 2012;12:812\u2013816. doi: 10.1089/vbz.2011.0694.", "ArticleIdList": ["10.1089/vbz.2011.0694", "22007611"]}, {"Citation": "Umair M., Khurshid A., Alam M.M., Akhtar R., Salman M., Ikram A. Genetic diversity and phylogenetic analysis of Crimean-Congo Hemorrhagic Fever viruses circulating in Pakistan during 2019. PLoS Negl. Trop. Dis. 2020;14:e0008238. doi: 10.1371/journal.pntd.0008238.", "ArticleIdList": ["10.1371/journal.pntd.0008238", "PMC7351229", "32598383"]}, {"Citation": "Alam M.M., Khurshid A., Sharif S., Shaukat S., Rana M.S., Angez M., Zaidi S.S. Genetic analysis and epidemiology of Crimean Congo Hemorrhagic fever viruses in Baluchistan province of Pakistan. BMC Infect. Dis. 2013;13:201. doi: 10.1186/1471-2334-13-201.", "ArticleIdList": ["10.1186/1471-2334-13-201", "PMC3652740", "23641865"]}, {"Citation": "Zhang L. Multi-epitope vaccines: A promising strategy against tumors and viral infections. Cell. Mol. Immunol. 2018;15:182\u2013184. doi: 10.1038/cmi.2017.92.", "ArticleIdList": ["10.1038/cmi.2017.92", "PMC5811687", "28890542"]}, {"Citation": "Amanna I.J., Slifka M.K. Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology. 2011;411:206\u2013215. doi: 10.1016/j.virol.2010.12.016.", "ArticleIdList": ["10.1016/j.virol.2010.12.016", "PMC3238379", "21216425"]}, {"Citation": "Nabel G.J. HIV vaccine strategies. Vaccine. 2002;20:1945\u20131947. doi: 10.1016/S0264-410X(02)00074-9.", "ArticleIdList": ["10.1016/S0264-410X(02)00074-9", "11983251"]}, {"Citation": "Sweredoski M.J., Baldi P. COBEpro: A novel system for predicting continuous B-cell epitopes. Protein Eng. Des. Sel. 2009;22:113\u2013120. doi: 10.1093/protein/gzn075.", "ArticleIdList": ["10.1093/protein/gzn075", "PMC2644406", "19074155"]}, {"Citation": "Duffy L., O\u2019Reilly S.C. Toll-like receptors in the pathogenesis of autoimmune diseases: Recent and emerging translational developments. Immunotargets Ther. 2016;5:69\u201380. doi: 10.2147/ITT.S89795.", "ArticleIdList": ["10.2147/ITT.S89795", "PMC5001654", "27579291"]}, {"Citation": "Liu W., Lu Y., Chen Y. Bioinformatics analysis of SARS-CoV M protein provides information for vaccine development. Prog. Nat. Sci. 2003;13:844\u2013847. doi: 10.1080/10020070312331344530.", "ArticleIdList": ["10.1080/10020070312331344530"]}, {"Citation": "Sedeyn K., Schepens B., Saelens X. Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses. PLoS Pathog. 2019;15:e1007984. doi: 10.1371/journal.ppat.1007984.", "ArticleIdList": ["10.1371/journal.ppat.1007984", "PMC6797084", "31622448"]}, {"Citation": "Hall T. BioEdit version 7.0.0. 2004.  [(accessed on 10 October 2022)].  Available online:  www.mbio.ncsu.edu/BioEdit/bioedit.html."}, {"Citation": "Kolaskar A.S., Tongaonkar P.C. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 1990;276:172\u2013174. doi: 10.1016/0014-5793(90)80535-Q.", "ArticleIdList": ["10.1016/0014-5793(90)80535-Q", "1702393"]}, {"Citation": "Sami S.A., Marma K.K.S., Mahmud S., Khan M.A.N., Albogami S., El-Shehawi A.M., Rakib A., Chakraborty A., Mohiuddin M., Dhama K., et al. Designing of a Multi-epitope Vaccine against the Structural Proteins of Marburg Virus Exploiting the Immunoinformatics Approach. ACS Omega. 2021;6:32043\u201332071. doi: 10.1021/acsomega.1c04817.", "ArticleIdList": ["10.1021/acsomega.1c04817", "PMC8638006", "34870027"]}, {"Citation": "Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993;26:283\u2013291. doi: 10.1107/S0021889892009944.", "ArticleIdList": ["10.1107/S0021889892009944"]}, {"Citation": "Valkenburg S.A., Josephs T.M., Clemens E.B., Grant E.J., Nguyen T.H., Wang G.C., Price D.A., Miller A., Tong S.Y., Thomas P.G., et al. Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses. Proc. Natl. Acad. Sci. USA. 2016;113:4440\u20134445. doi: 10.1073/pnas.1603106113.", "ArticleIdList": ["10.1073/pnas.1603106113", "PMC4843436", "27036003"]}, {"Citation": "Theodossis A., Guillonneau C., Welland A., Ely L.K., Clements C.S., Williamson N.A., Webb A.I., Wilce J.A., Mulder R.J., Dunstone M.A. Constraints within major histocompatibility complex class I restricted peptides: Presentation and consequences for T-cell recognition. Proc. Natl. Acad. Sci. USA. 2010;107:5534\u20135539. doi: 10.1073/pnas.1000032107.", "ArticleIdList": ["10.1073/pnas.1000032107", "PMC2851776", "20212169"]}, {"Citation": "Molecular Operating Environment (MOE), 2022.02. Chemical Computing Group ULC; Montreal, QC, Canada: 2022."}, {"Citation": "Blender O. Blender\u2014A 3D modelling and rendering package. Retrieved. represents the sequence of Constructs1 to. 2018;4"}, {"Citation": "Case D.A., Belfon H.M.A.K., Ben-Shalom I.Y., Berryman J.T., Brozell S.R., Cerutti D.S., Cheatham T.E., Cisneros G.A., III, Cruzeiro V.W.D., Darden T.A., et al. Amber2022. University of California; San Francisco, CA, USA: 2022.", "ArticleIdList": ["0"]}, {"Citation": "Tian C., Kasavajhala K., Belfon K.A.A., Raguette L., Huang H., Migues A.N., Bickel J., Wang Y., Pincay J., Wu Q., et al. ff19SB: Amino-Acid-Specific Protein Backbone Parameters Trained against Quantum Mechanics Energy Surfaces in Solution. J. Chem. Theory Comput. 2020;16:528\u2013552. doi: 10.1021/acs.jctc.9b00591.", "ArticleIdList": ["10.1021/acs.jctc.9b00591", "31714766"]}, {"Citation": "Salomon-Ferrer R., Gotz A.W., Poole D., Le Grand S., Walker R.C. Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald. J. Chem. Theory Comput. 2013;9:3878\u20133888. doi: 10.1021/ct400314y.", "ArticleIdList": ["10.1021/ct400314y", "26592383"]}, {"Citation": "Press W.H., Flannery B.P., Teukolsky S.A., Vetterling W.T., Kramer P.B. Numerical recipes: The art of scientific computing. Phys. Today. 1987;40:120. doi: 10.1063/1.2820230.", "ArticleIdList": ["10.1063/1.2820230"]}, {"Citation": "Sindhikara D.J., Kim S., Voter A.F., Roitberg A.E. Bad Seeds Sprout Perilous Dynamics: Stochastic Thermostat Induced Trajectory Synchronization in Biomolecules. J. Chem. Theory Comput. 2009;5:1624\u20131631. doi: 10.1021/ct800573m.", "ArticleIdList": ["10.1021/ct800573m", "26609854"]}, {"Citation": "Kr\u00e4utler V., Van Gunsteren W.F., H\u00fcnenberger P.H. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J. Comput. Chem. 2001;22:501\u2013508. doi: 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V.", "ArticleIdList": ["10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V"]}, {"Citation": "Roe D.R., Cheatham T.E., 3rd PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. J. Chem. Theory Comput. 2013;9:3084\u20133095. doi: 10.1021/ct400341p.", "ArticleIdList": ["10.1021/ct400341p", "26583988"]}, {"Citation": "Hou T., Wang J., Li Y., Wang W. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J. Chem. Inf. Model. 2011;51:69\u201382. doi: 10.1021/ci100275a.", "ArticleIdList": ["10.1021/ci100275a", "PMC3029230", "21117705"]}, {"Citation": "Yang T., Wu J.C., Yan C., Wang Y., Luo R., Gonzales M.B., Dalby K.N., Ren P. Virtual screening using molecular simulations. Proteins. 2011;79:1940\u20131951. doi: 10.1002/prot.23018.", "ArticleIdList": ["10.1002/prot.23018", "PMC3092865", "21491494"]}, {"Citation": "Kollman P.A., Massova I., Reyes C., Kuhn B., Huo S., Chong L., Lee M., Lee T., Duan Y., Wang W., et al. Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Acc. Chem. Res. 2000;33:889\u2013897. doi: 10.1021/ar000033j.", "ArticleIdList": ["10.1021/ar000033j", "11123888"]}, {"Citation": "Dong R., Chu Z., Yu F., Zha Y. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches. Front. Immunol. 2020;11:1784. doi: 10.3389/fimmu.2020.01784.", "ArticleIdList": ["10.3389/fimmu.2020.01784", "PMC7399176", "32849643"]}, {"Citation": "Jyotisha, Singh S., Qureshi I.A. Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches. J. Biomol. Struct. Dyn. 2022;40:2917\u20132933. doi: 10.1080/07391102.2020.1844060.", "ArticleIdList": ["10.1080/07391102.2020.1844060", "PMC7682209", "33164664"]}, {"Citation": "Rakib A., Sami S.A., Mimi N.J., Chowdhury M.M., Eva T.A., Nainu F., Paul A., Shahriar A., Tareq A.M., Emon N.U., et al. Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein. Comput. Biol. Med. 2020;124:103967. doi: 10.1016/j.compbiomed.2020.103967.", "ArticleIdList": ["10.1016/j.compbiomed.2020.103967", "PMC7423576", "32828069"]}, {"Citation": "Sharma R., Rajput V.S., Jamal S., Grover A., Grover S. An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins. Sci. Rep. 2021;11:13836. doi: 10.1038/s41598-021-93266-w.", "ArticleIdList": ["10.1038/s41598-021-93266-w", "PMC8257786", "34226593"]}, {"Citation": "Yu M., Zhu Y., Li Y., Chen Z., Li Z., Wang J., Li Z., Zhang F., Ding J. Design of a recombinant multivalent epitope vaccine based on SARS-CoV-2 and its variants in Immunoinformatics approach. Front. Immunol. 2022;13:2116.", "ArticleIdList": ["PMC9120605", "35603198"]}, {"Citation": "Guo L., Yin R., Liu K., Lv X., Li Y., Duan X., Chu Y., Xi T., Xing Y. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model. Appl. Microbiol. Biotechnol. 2014;98:3495\u20133507. doi: 10.1007/s00253-013-5408-6.", "ArticleIdList": ["10.1007/s00253-013-5408-6", "24370888"]}, {"Citation": "Cao Y., Li D., Fu Y., Bai Q., Chen Y., Bai X., Jing Z., Sun P., Bao H., Li P., et al. Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs. Antivir. Res. 2017;140:133\u2013141. doi: 10.1016/j.antiviral.2017.01.023.", "ArticleIdList": ["10.1016/j.antiviral.2017.01.023", "28161579"]}, {"Citation": "Lennerz V., Gross S., Gallerani E., Sessa C., Mach N., Boehm S., Hess D., von Boehmer L., Knuth A., Ochsenbein A.F., et al. Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors. Cancer Immunol. Immunother. 2014;63:381\u2013394. doi: 10.1007/s00262-013-1516-5.", "ArticleIdList": ["10.1007/s00262-013-1516-5", "24487961"]}, {"Citation": "Slingluff C.L., Lee S., Zhao F., Chianese-Bullock K.A., Olson W.C., Butterfield L.H., Whiteside T.L., Leming P.D., Kirkwood J.M. A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602) Multipeptide Vaccine for Advanced Melanoma. Clin. Cancer Res. 2013;19:4228\u20134238. doi: 10.1158/1078-0432.CCR-13-0002.", "ArticleIdList": ["10.1158/1078-0432.CCR-13-0002", "PMC3813832", "23653149"]}, {"Citation": "Toledo H., Baly A., Castro O., Resik S., Laferte J., Rolo F., Navea L., Lobaina L., Cruz O., Miguez J., et al. A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers. Vaccine. 2001;19:4328\u20134336. doi: 10.1016/S0264-410X(01)00111-6.", "ArticleIdList": ["10.1016/S0264-410X(01)00111-6", "11457560"]}, {"Citation": "Gadelha C., Zhang W., Chamberlain J.W., Chait B.T., Wickstead B., Field M.C. Architecture of a host\u2013parasite interface: Complex targeting mechanisms revealed through proteomics. Mol. Cell. Proteom. 2015;14:1911\u20131926. doi: 10.1074/mcp.M114.047647.", "ArticleIdList": ["10.1074/mcp.M114.047647", "PMC4587319", "25931509"]}, {"Citation": "Chaplin D.D. Overview of the immune response. J. Allergy Clin. Immunol. 2010;125:S3\u2013S23. doi: 10.1016/j.jaci.2009.12.980.", "ArticleIdList": ["10.1016/j.jaci.2009.12.980", "PMC2923430", "20176265"]}, {"Citation": "Solberg O.D., Mack S.J., Lancaster A.K., Single R.M., Tsai Y., Sanchez-Mazas A., Thomson G. Balancing selection and heterogeneity across the classical human leukocyte antigen loci: A meta-analytic review of 497 population studies. Hum. Immunol. 2008;69:443\u2013464. doi: 10.1016/j.humimm.2008.05.001.", "ArticleIdList": ["10.1016/j.humimm.2008.05.001", "PMC2632948", "18638659"]}, {"Citation": "Athanasiou E., Agallou M., Tastsoglou S., Kammona O., Hatzigeorgiou A., Kiparissides C., Karagouni E. A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNgamma-Producing CD8(+) T Cells Essential for the Protection against Experimental Visceral Leishmaniasis. Front. Immunol. 2017;8:684. doi: 10.3389/fimmu.2017.00684.", "ArticleIdList": ["10.3389/fimmu.2017.00684", "PMC5468442", "28659922"]}, {"Citation": "Banerjee S., Majumder K., Gutierrez G.J., Gupta D., Mittal B. Immuno-informatics approach for multi-epitope vaccine designing against SARS-CoV-2. bioRxiv. 2020 doi: 10.1101/2020.07.23.218529.", "ArticleIdList": ["10.1101/2020.07.23.218529"]}, {"Citation": "Fadaka A.O., Sibuyi N.R.S., Martin D.R., Goboza M., Klein A., Madiehe A.M., Meyer M. Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus. Sci. Rep. 2021;11:19707. doi: 10.1038/s41598-021-99227-7.", "ArticleIdList": ["10.1038/s41598-021-99227-7", "PMC8492693", "34611250"]}, {"Citation": "Rouzbahani A.K., Kheirandish F., Hosseini S.Z. Design of a multi-epitope-based peptide vaccine against the S and N proteins of SARS-CoV-2 using immunoinformatics approach. Egypt. J. Med. Hum. Genet. 2022;23:1\u201318. doi: 10.1186/s43042-022-00224-w.", "ArticleIdList": ["10.1186/s43042-022-00224-w", "PMC8813187", "37521850"]}, {"Citation": "Shey R.A., Ghogomu S.M., Esoh K.K., Nebangwa N.D., Shintouo C.M., Nongley N.F., Asa B.F., Ngale F.N., Vanhamme L., Souopgui J. In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases. Sci. Rep. 2019;9:4409. doi: 10.1038/s41598-019-40833-x.", "ArticleIdList": ["10.1038/s41598-019-40833-x", "PMC6416346", "30867498"]}, {"Citation": "Dolenc I., Seemuller E., Baumeister W. Decelerated degradation of short peptides by the 20S proteasome. FEBS Lett. 1998;434:357\u2013361. doi: 10.1016/S0014-5793(98)01010-2.", "ArticleIdList": ["10.1016/S0014-5793(98)01010-2", "9742954"]}, {"Citation": "Yang Y., Sun W., Guo J., Zhao G., Sun S., Yu H., Guo Y., Li J., Jin X., Du L., et al. In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations. Hum. Vaccin. Immunother. 2015;11:795\u2013805. doi: 10.1080/21645515.2015.1012017.", "ArticleIdList": ["10.1080/21645515.2015.1012017", "PMC4514284", "25839222"]}, {"Citation": "Livingston B., Crimi C., Newman M., Higashimoto Y., Appella E., Sidney J., Sette A. A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes. J. Immunol. 2002;168:5499\u20135506. doi: 10.4049/jimmunol.168.11.5499.", "ArticleIdList": ["10.4049/jimmunol.168.11.5499", "12023344"]}, {"Citation": "Chen X., Zaro J.L., Shen W.C. Fusion protein linkers: Property, design and functionality. Adv. Drug Deliv. Rev. 2013;65:1357\u20131369. doi: 10.1016/j.addr.2012.09.039.", "ArticleIdList": ["10.1016/j.addr.2012.09.039", "PMC3726540", "23026637"]}, {"Citation": "Sanches R.C., Tiwari S., Ferreira L.C., Oliveira F.M., Lopes M.D., Passos M.J., Maia E.H., Taranto A.G., Kato R., Azevedo V.A. Immunoinformatics design of multi-epitope peptide-based vaccine against Schistosoma mansoni using transmembrane proteins as a target. Front. Immunol. 2021;12:621706. doi: 10.3389/fimmu.2021.621706.", "ArticleIdList": ["10.3389/fimmu.2021.621706", "PMC7961083", "33737928"]}, {"Citation": "Apostolico Jde S., Lunardelli V.A., Coirada F.C., Boscardin S.B., Rosa D.S. Adjuvants: Classification, Modus Operandi, and Licensing. J. Immunol. Res. 2016;2016:14593\u201314594. doi: 10.1155/2016/1459394.", "ArticleIdList": ["10.1155/2016/1459394", "PMC4870346", "27274998"]}, {"Citation": "Lee S.J., Shin S.J., Lee M.H., Lee M.G., Kang T.H., Park W.S., Soh B.Y., Park J.H., Shin Y.K., Kim H.W., et al. A potential protein adjuvant derived from Mycobacterium tuberculosis Rv0652 enhances dendritic cells-based tumor immunotherapy. PLoS ONE. 2014;9:e104351. doi: 10.1371/journal.pone.0104351.", "ArticleIdList": ["10.1371/journal.pone.0104351", "PMC4125215", "25102137"]}, {"Citation": "Droppa-Almeida D., Franceschi E., Padilha F.F. Immune-Informatic Analysis and Design of Peptide Vaccine From Multi-epitopes Against Corynebacterium pseudotuberculosis. Bioinform. Biol. Insights. 2018;12:1177932218755337. doi: 10.1177/1177932218755337.", "ArticleIdList": ["10.1177/1177932218755337", "PMC5954444", "29780242"]}, {"Citation": "Rekik I., Chaabene Z., Grubb C.D., Drira N., Cheour F., Elleuch A. In silico characterization and Molecular modeling of double-strand break repair protein MRE11 from Phoenix dactylifera v deglet nour. Theor. Biol. Med. Model. 2015;12:23. doi: 10.1186/s12976-015-0013-2.", "ArticleIdList": ["10.1186/s12976-015-0013-2", "PMC4635681", "26541955"]}, {"Citation": "Janeway C.A., Jr., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002;20:197\u2013216. doi: 10.1146/annurev.immunol.20.083001.084359.", "ArticleIdList": ["10.1146/annurev.immunol.20.083001.084359", "11861602"]}, {"Citation": "Carty M., Bowie A.G. Recent insights into the role of Toll-like receptors in viral infection. Clin. Exp. Immunol. 2010;161:397\u2013406. doi: 10.1111/j.1365-2249.2010.04196.x.", "ArticleIdList": ["10.1111/j.1365-2249.2010.04196.x", "PMC2962956", "20560984"]}, {"Citation": "Zheng W., Xu Q., Zhang Y., Gao W., Zhang M., Zhai W., Rajkumar R.S., Liu Z. Toll-like receptor-mediated innate immunity against herpesviridae infection: A current perspective on viral infection signaling pathways. Virol. J. 2020;17:1\u201315.", "ArticleIdList": ["PMC7726878", "33298111"]}, {"Citation": "Compton T., Kurt-Jones E.A., Boehme K.W., Belko J., Latz E., Golenbock D.T., Finberg R.W. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 2003;77:4588\u20134596. doi: 10.1128/JVI.77.8.4588-4596.2003.", "ArticleIdList": ["10.1128/JVI.77.8.4588-4596.2003", "PMC152130", "12663765"]}, {"Citation": "Vercammen E., Staal J., Beyaert R. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin. Microbiol. Rev. 2008;21:13\u201325. doi: 10.1128/CMR.00022-07.", "ArticleIdList": ["10.1128/CMR.00022-07", "PMC2223843", "18202435"]}, {"Citation": "Jia S., Li C., Pan H., Wang M., Wang X., Lin Q. Preparation and pore-forming mechanism of hydrogen bond and ionic bond double-driven chitosan-based mesoporous carbon. Int. J. Biol. Macromol. 2021;179:519\u2013531. doi: 10.1016/j.ijbiomac.2021.03.024.", "ArticleIdList": ["10.1016/j.ijbiomac.2021.03.024", "33689772"]}, {"Citation": "Hollingsworth S.A., Dror R.O. Molecular dynamics simulation for all. Neuron. 2018;99:1129\u20131143. doi: 10.1016/j.neuron.2018.08.011.", "ArticleIdList": ["10.1016/j.neuron.2018.08.011", "PMC6209097", "30236283"]}, {"Citation": "Lippert T., Rarey M. Fast automated placement of polar hydrogen atoms in protein-ligand complexes. J. Cheminform. 2009;1:13. doi: 10.1186/1758-2946-1-13.", "ArticleIdList": ["10.1186/1758-2946-1-13", "PMC3225823", "20298519"]}, {"Citation": "Eagen R., Kim S.H., Kronstad J.W., Breuil C. An hydroxynaphtalene reductase gene from the wood-staining fungus Ophiostoma floccosum complements the buff phenotype in Magnaporthe grisea. Mycol. Res. 2001;105:461\u2013469. doi: 10.1017/S0953756201003744.", "ArticleIdList": ["10.1017/S0953756201003744"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "24"}, {"Year": "2022", "Month": "12", "Day": "15"}, {"Year": "2022", "Month": "12", "Day": "22"}, {"Year": "2023", "Month": "1", "Day": "21", "Hour": "1", "Minute": "57"}, {"Year": "2023", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "22", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "12", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["36679906", "PMC9867508", "10.3390/vaccines11010061", "vaccines11010061"]}}], "PubmedBookArticle": []}